Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-National Randomized Phase-III GCIG Intergroup-Study Comparing 1st-line Chemotherapy With Gemcitabine/Paclitaxel/Carboplatin vs Paclitaxel/Carboplatin In Previously Untreated Patients With Epithelial Ovarian Cancer FIGO Stages I-IV

NCT00052468 is registered in ClinicalTrials.gov with AGO Study Group as lead sponsor.

NCT NCT00052468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00052468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-National Randomized Phase-III GCIG Intergroup-Study Comparing 1st-line Chemotherapy With Gemcitabine/Paclitaxel/Carboplatin vs Paclitaxel/Carboplatin In Previously Untreated Patients With Epithelial Ovarian Cancer FIGO Stages I-IV
Lead sponsor
AGO Study Group
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2002
Completion date
January 31, 2011
Enrollment
1,742 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

fallopian tube cancer, ovarian cancer